258 related articles for article (PubMed ID: 29777867)
1. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
[TBL] [Abstract][Full Text] [Related]
2. Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant.
Ogimi C; Krantz EM; Golob JL; Liu C; Waghmare A; Akramoff A; Mallory A; Leisenring WM; Jerome KR; Chow VA; Pergam SA; Fredricks DN; Englund JA; Boeckh M
Bone Marrow Transplant; 2022 Dec; 57(12):1765-1773. PubMed ID: 36064752
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.
Seo S; Xie H; Leisenring WM; Kuypers JM; Sahoo FT; Goyal S; Kimball LE; Campbell AP; Jerome KR; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2019 Jan; 25(1):163-171. PubMed ID: 30149147
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
Sheshadri A; Chemaly RF; Alousi AM; Shah PK; Rondon G; Bashoura L; Kmeid J; Azzi J; Blanco DW; Kaous M; Dickey BF; Champlin RE; Shah DP
Biol Blood Marrow Transplant; 2019 Apr; 25(4):800-809. PubMed ID: 30521974
[TBL] [Abstract][Full Text] [Related]
5. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.
Seo S; Xie H; Campbell AP; Kuypers JM; Leisenring WM; Englund JA; Boeckh M
Clin Infect Dis; 2014 May; 58(10):1357-68. PubMed ID: 24599766
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.
Ogimi C; Waghmare AA; Kuypers JM; Xie H; Yeung CC; Leisenring WM; Seo S; Choi SM; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2017 Jun; 64(11):1532-1539. PubMed ID: 28329354
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
8. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Tridello G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmenniemi U; Perez A; Kröger N; Cornelissen J; Sala E; Martino R; Geurten C; Byrne J; Maertens J; Kerre T; Martin M; Pascual MJ; Yeshurun M; Finke J; Groll AH; Shaw PJ; Blijlevens N; Arcese W; Ganser A; Suarez-Lledo M; Alzahrani M; Choi G; Forcade E; Paviglianiti A; Solano C; Wachowiak J; Zuckerman T; Bader P; Clausen J; Mayer J; Schroyens W; Metafuni E; Knelange N; Averbuch D; de la Camara R
J Infect Dis; 2024 Jan; 229(1):83-94. PubMed ID: 37440459
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
Waghmare A; Campbell AP; Xie H; Seo S; Kuypers J; Leisenring W; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2013 Dec; 57(12):1731-41. PubMed ID: 24065324
[TBL] [Abstract][Full Text] [Related]
11. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
12. Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.
Ison MG; Marty FM; Chao N; Moon SH; Zhang Z; Chandak A
Transpl Infect Dis; 2022 Aug; 24(4):e13866. PubMed ID: 35598293
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Fisher BT; Danziger-Isakov L; Sweet LR; Munoz FM; Maron G; Tuomanen E; Murray A; Englund JA; Dulek D; Halasa N; Green M; Michaels MG; Madan RP; Herold BC; Steinbach WJ
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):275-282. PubMed ID: 29106589
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.
Kim YJ; Guthrie KA; Waghmare A; Walsh EE; Falsey AR; Kuypers J; Cent A; Englund JA; Boeckh M
J Infect Dis; 2014 Apr; 209(8):1195-204. PubMed ID: 24368837
[TBL] [Abstract][Full Text] [Related]
15. Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation.
Hutspardol S; Essa M; Richardson S; Schechter T; Ali M; Krueger J; Fujii H; Egeler RM; Gassas A
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1802-7. PubMed ID: 26117558
[TBL] [Abstract][Full Text] [Related]
16. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754
[TBL] [Abstract][Full Text] [Related]
17. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
Peck AJ; Englund JA; Kuypers J; Guthrie KA; Corey L; Morrow R; Hackman RC; Cent A; Boeckh M
Blood; 2007 Sep; 110(5):1681-8. PubMed ID: 17502457
[TBL] [Abstract][Full Text] [Related]
18. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Milano F; Englund JA; Boeckh M
J Clin Virol; 2022 Jun; 150-151():105152. PubMed ID: 35447514
[TBL] [Abstract][Full Text] [Related]
19. Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes.
Kim YJ; Waghmare A; Xie H; Holmberg L; Pergam SA; Jerome KR; Leisenring WM; Ogimi C; Campbell AP; Englund JA; Boeckh M
Blood Adv; 2022 Sep; 6(18):5307-5316. PubMed ID: 35446933
[TBL] [Abstract][Full Text] [Related]
20. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
